FDA Drug Application (091215) for EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE by TEVA PHARMS

Back to FDA Applications sponsored by TEVA PHARMS

Application Number091215
Product Number001
FormTABLET; ORAL
Dosage600MG; 200MG; 300MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameEFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
Active IngredientEFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE



Back to FDA Applications sponsored by TEVA PHARMS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.